Published on: March 26, 2018
by Medical XPress:
Initiating an opioid analgesic reduced the use of antipsychotics and benzodiazepines in persons with Alzheimer’s disease, a recent study from the University of Eastern Finland shows. These drugs are frequently prescribed to treat behavioural and psychiatric symptoms of dementia, which can be worsened by other symptoms, such as pain. The results were published in International Psychogeriatrics.
The researchers analysed the use of antipsychotics and benzodiazepines six months before and six months after persons with Alzheimer’s disease begun using an opioid. These results were then compared to persons with Alzheimer’s disease who did not initiate opioid use. After the initiation of an opioid, the researchers found a downward trend in the prevalence of both antipsychotics and benzodiazepines, with the prevalence of antipsychotics reducing more.
The use of antipsychotics and benzodiazepines is very frequent in persons with Alzheimer’s disease, but it carries a risk for severe adverse effects, and long-term treatment is generally not recommended. Previous studies have found a decrease in behavioural and psychiatric symptoms of dementia when patients are treated for pain, but this new study now shows, for the first time, a decrease in symptomatic drug use. The study is also the world’s first nationwide study on the subject. The results provide further evidence on the importance of proper diagnosis and treatment of pain among persons with dementia.
The study is part of the MEDALZ cohort, which included 3,327 persons with Alzheimer’s disease diagnosed during 2010–2011. Each person initiating opioid use was matched with a comparison person with Alzheimer’s disease who did not initiate opioid use but was of the same age, gender and region of residence. Data for the study were derived from Finnish nationwide registers.
Source: https://medicalxpress.com/news/2018-03-opioid-analgesics-antipsychotics-persons-alzheimer.html
Thanks to the ongoing support of our partner Brain Canada, and The Citrine Foundation of Canada, Women’s Brain Health Initiative’s newest edition of MIND OVER MATTER has just been published. Loaded with interesting science-based articles, MIND OVER...
On December 2nd, in celebration of Women’s Brain Health Day, join thousands of others and take part in the Stand Ahead® Memory Challenge to stand up against research bias and stand ahead for women’s brain...
YOU’RE INVITED! On December 2nd, the second annual Women’s Brain Health Day, take the memory challenge and help us combat brain-aging diseases that disproportionately affect women. Join CTV’s Pattie Lovett-Reid and Anne-Marie Mediwake, along...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.
